Patent Application
20220280748
Described herein are apparatuses (e.g., device and systems) and methods for enhancing sleep, including in particular enhancing the quality of sleep, reducing sleep onset time, increasing total sleep time, treating insomnia and treating other neurological disorders by non-invasively regulating the temperature of the frontal cortex prior to and/or during sleep.
Sleep is essential for a person's health and wellbeing, yet millions of people do not get enough sleep and many suffer from lack of sleep. Surveys conducted by the U.S. National Science Foundation between 1999 and 2004 found that at least 40 million Americans suffer from over 70 different sleep disorders, and 60 percent of adults report having sleep problems a few nights a week or more. Most of those with these problems go undiagnosed and untreated. In addition, more than 40 percent of adults experience daytime sleepiness severe enough to interfere with their daily activities at least a few days each month, with 20 percent reporting problem sleepiness a few days a week or more. Furthermore, 69 percent of children experience one or more sleep problems a few nights or more during a week.
Insomnia is the most common sleep complaint across all stages of adulthood, and for millions of people, the problem is chronic. Many health and lifestyle factors contribute to insomnia including stress, depression, medical illnesses, pain, medications, or specific sleeping disorders. There is great need for additional research to better define the nature of chronic insomnia.
Existing treatments of neurological and/or sleeping disorders, including insomnia, include the use of over the counter or prescription drugs and/or behavioral treatments. Prescription drugs are known to aid patients suffering from sleeping disorders, however, these drugs are quite expensive and potentially addicting. Some medications even become less effective as use continues. Additionally, the prescriptions sometimes have unwanted and harmful side effects.
Other techniques to treat sleeping disorders include a variety of behavioral measures including stimulus control therapy, sleep restriction therapy, relaxation training, cognitive therapy, and sleep hygiene education. While these measures have moderate effectiveness, they are costly, require significant time to implement and require highly trained clinicians to implement.
One treatment technique previously described addresses these issues by using non-invasive and localized or regional thermal stimuli to the brain that helps treat sleep disorders, including insomnia. Specifically, this method helps restore or mimic normal function in the cerebral cortex. The restoration of function in the cerebral cortex plays a significant role in sleep. At the molecular and neuronal levels, hypothesized functions of sleep include the restoration of brain energy metabolism through the replenishment of brain glycogen stores that are depleted during wakefulness and the downscaling of synapses that have been potentiated during waking brain function. A homeostatic sleep drive, or pressure for sleep, is known to build throughout the waking hours and then is discharged during sleep. At the electroencephalographic (EEG) level, this is measured by EEG spectral power in the delta (0.5-4 Hz) frequency band.
These sleep-related processes have some regional specificity for the prefrontal cortex. Slow wave sleep rhythms have both thalamic and cortical components. An anterior dominance of EEG spectral power in the delta EEG spectral power range has been reported. A frontal predominance for the increase in delta power following sleep loss has been also reported. This region of the cortex also plays a prominent role in waking executive functions which are preferentially impaired following sleep deprivation. This sleep deprivation induced cognitive impairments have been related to declines in frontal metabolism after sleep loss. While cerebral metabolism declines globally from waking to NREM sleep, these declines are most pronounced in heteromodal association cortex, including the prefrontal cortex.
Insomnia is associated with global cerebral hypermetabolism. Nofzinger et al. (Am J Psychiatry, 2004) assessed regional cerebral glucose metabolism during both waking and NREM sleep in insomnia patients and healthy subjects using [18F] fluoro-2-deoxy-D-glucose positron emission tomography (PET). Insomnia patients show increased global cerebral glucose metabolism during sleep and wakefulness; and a smaller decline in relative metabolism from wakefulness to sleep in wake-promoting regions of the brain. In a comparison between insomnia and depressed patients, insomnia patients demonstrated increased waking relative metabolism in the prefrontal cortex. Finally, recent research has shown that the amount of wakefulness after sleep onset, or WASO, in insomnia patients correlates with increasing metabolism in the prefrontal cortex during NREM sleep.
The relationship between body temperature and quality of sleep generally has been described in connection with prior research in the field of sleep medicine. Heat loss, via selective vasodilatation of distal skin regions (measured by the distal minus proximal skin temperature gradient (DPG), seems to be a crucial process for the circadian regulation of core body temperature (CBT) and sleepiness (Aschoff 1956; Krauchi and Wirz-Justice 1994, 2002; Krauchi et al. 1998, 2000). Increased DPG before lights off has been noted to promote a rapid onset of sleep, suggesting a link between thermoregulatory and arousal (sleepiness) systems (Krauchi et al. 1999, 2000). Hot environments impair the sleep process including falling asleep and maintaining sleep as well as generating slow wave sleep as the increased ambient temperature interferes with the normal declines in core body temperature associated with the sleep onset process. Finally, rapid and intense temperature drops around the sleep onset or sleeping periods are expected to have an arousing effect (Home and Reyner 1999; Hayashi et al. 2003). In contrast, the apparatuses and methods described herein minimize such adverse effects from temperature changes through application of a controlled (including relatively constant) thermal regulation over a prolonged period of time to a localized surface of the scalp. Thus, it has been found that noninvasive, regional thermal stimulus to the scalp (e.g., between 10 degrees C. and 40 degrees C.) of the head often helps adjust metabolism in the cerebral cortex underlying the stimulus and, thereby, provides treatment for neurological disorders.
Previously described technologies for brain temperature regulation (e.g., cooling) sometimes utilized a cooling apparatus configured to be placed over the scalp/head immediately atop the frontal cortex region, and cooling of the apparatus is typically applied by circulating coolant, although other cooling mechanisms are discussed. Described herein are advancements and further refinements of this early work, expanding the types of thermal regulation apparatuses that are able to be used, as well as ways for securing the apparatus to the proper region of a patient's head.
In general, described herein are non-invasive methods and apparatuses (including devices and systems) for applying thermal therapy to the skin over the prefrontal cortex. In some variations, the apparatuses and methods of using them to enhance sleep accomplish sustained thermal regulation (warming or cooling) in an appropriate therapeutic range and time using one or more phase change materials. Also described are devices and methods to enhance sleep that accomplish sustained thermal regulation (cooling) in an appropriate therapeutic range and time using sustained evaporative cooling to enhance sleep. Finally, also descried herein is headgear that is specifically adapted to hold a thermal applicator to provide sustained thermal regulation in the appropriate anatomical region of the head.
In one embodiment, the present invention is directed to a method of improving sleep by non-invasively applying hypothermal therapy to a user's forehead, including placing a thermal transfer region in communication with the skin of a user on the forehead of the user, the thermal transfer region including at least one Peltier device operable to cool the skin of the user, activating the at least one Peltier device and cooling the thermal transfer region to a set temperature between about 14° C. and about 18° C., and maintaining the set temperature for a time period extending at least 15 minutes.
In another embodiment, the present invention is directed to a method of improving sleep by non-invasively applying hypothermal therapy to a user's forehead, including placing a thermal transfer region in communication with the skin of a user on the forehead of the user, the thermal transfer region including at least one Peltier device operable to cool the skin of the user, and activating the at least one Peltier device and cooling the thermal transfer region to a set temperature between about 14° C. and about 18° C., wherein the thermal transfer region further includes at least one phase change material.
In yet another embodiment, the present invention is directed to a method of improving sleep by non-invasively applying hypothermal therapy to a user's forehead, including placing a thermal transfer region in communication with the skin of a user on the forehead of the user, the thermal transfer region including at least one phase change material operable to cool the skin of the user, and maintaining the set temperature for a time period extending at least 15 minutes, wherein the at least one phase change material has a phase transition between about 10 degrees C. and about 18 degrees C.
These and other aspects of the present invention will become apparent to those skilled in the art after a reading of the following description of the preferred embodiment when considered with the drawings, as they support the claimed invention.
In general, described herein are thermal regulation applicators that are specifically configured to be comfortably worn on the subject's head, to thermally regulate (e.g., hold to a predetermined temperature) specific regions of the subject's brain (e.g., the frontal cortex region/prefrontal cortex) while remaining comfortable, and sustaining the temperature of the specific region of the head at a desired temperature for a specific one or more periods of time. In general, these devices include a thermal transfer region to be worn directly against the subject's skin (in the head region above the frontal cortex) and a thermal regulator region passively holding the predetermined temperature (or predetermined temperature range) which is in thermal contact with the thermal transfer region. All of the apparatuses (devices and systems) herein described are intended to address the subjects comfort while the applicator is maintained in a position above the pre-frontal (or frontal) cortex.
In one embodiment, the present invention is directed to a method of improving sleep by non-invasively applying hypothermal therapy to a user's forehead, including placing a thermal transfer region in communication with the skin of a user on the forehead of the user, the thermal transfer region including at least one Peltier device operable to cool the skin of the user, activating the at least one Peltier device and cooling the thermal transfer region to a set temperature between about 14° C. and about 18° C., and maintaining the set temperature for a time period extending at least 15 minutes.
In another embodiment, the present invention is directed to a method of improving sleep by non-invasively applying hypothermal therapy to a user's forehead, including placing a thermal transfer region in communication with the skin of a user on the forehead of the user, the thermal transfer region including at least one Peltier device operable to cool the skin of the user, and activating the at least one Peltier device and cooling the thermal transfer region to a set temperature between about 14° C. and about 18° C., wherein the thermal transfer region further includes at least one phase change material.
In yet another embodiment, the present invention is directed to a method of improving sleep by non-invasively applying hypothermal therapy to a user's forehead, including placing a thermal transfer region in communication with the skin of a user on the forehead of the user, the thermal transfer region including at least one phase change material operable to cool the skin of the user, and maintaining the set temperature for a time period extending at least 15 minutes, wherein the at least one phase change material has a phase transition between about 10 degrees C. and about 18 degrees C.
In many of the therapeutic methods described herein, the apparatuses (devices or systems) include and applicator having a thermal transfer region and a phase change material that is configured to contact or be placed in thermal contact, with the patient's skin; specifically, the skin over the prefrontal cortex. The thermal transfer region is further temperature controlled by any appropriate thermal regulator region, particularly passive thermal regulator regions, which do not require active heating/cooling (by an electrically powered devices such as a heater/chiller, Peltier, etc.). For example, a passive thermal regulator includes a phase change material, evaporative cooling, or some combination thereof. Phase changing materials and sustained evaporative cooling are used specifically to provide appropriate therapeutic cooling in various embodiments described herein. Although passive thermal regulators are described in particular detail here, any of the applicators and methods described herein (unless the context indicates otherwise) are able to include an active thermal regulator in addition or in alternative. An active thermal regulator includes a fluid cooled/warmed, a solid state (e.g., Peltier device), or the like.
Also described herein are methods of enhancing the sleep, such as enhancing the quality of sleep, reducing sleep onset, sustaining sleep and/or treating insomnia by non-invasively applying thermal regulation to the subject's frontal cortex using an applicator including a phase-changing cooling region and/or evaporative cooling region. In general, these methods include: positioning an applicator having a phase change material or evaporative cooling region so that a thermal transfer region is in communication with the subject's skin over the prefrontal cortex, as shown in
For example, described herein are applicators to enhance sleep by regulating the temperature of a subject's frontal cortex when worn. An applicator includes: a thermal regulator region comprising a phase change material having a phase transition between about 10 degrees C. and about 40 degrees C.; a thermal transfer region in thermal communication with the thermal regulator region, wherein the thermal transfer regions is configured to conform to and to contact a subject's forehead so that the thermal transfer region is positioned against the subject's head over the frontal cortex; and a strap configured to hold the applicator against the subject's head when the subject is sleeping.
Any appropriate phase change material is able to be used. For example, a phase change material is a homogenous material (e.g., all a single material) or the phase change material is made up of a plurality of different phase change materials, each having a different phase transition temperature. The phase transition temperature in the case of a phase transition material that comprises a mixture of different component phase transition materials is the temperature (or temperatures) at which the temperature of the thermal regulator sustains by the passive release/absorption of energy during use (and following pre-chilling or pre-warming before use), for example, a temperature between about 10 degrees C. and about 40 degrees C.
In some variations the thermal regulator includes a plurality of smaller bodies including the phase change material. Examples of these smaller bodies include capsules or bodies otherwise encapsulating the phase change material. For example, the thermal regulator comprises a plurality of capsules, wherein each capsule encapsulates the phase change material. These capsules are able to be connected by another material (e.g., the material of the thermal transfer region or a different material), or suspended in another material. The material in which the capsules are held typically has a relatively high thermal conductivity (e.g., greater than about 0.1 watts per meter kelvin (W/(m*K)), 0.2 W/m*K, 0.3 W/m*K, 0.4 W/m*K, 0.5 W/m*K, 0.5 W/m*K, 0.7 W/m*K, 0.8 W/m*K, 0.9 W/m*K, 1 W/m*K, 2 W/m*K, 5 W/m*K, etc.). In some variations the thermal regulator region comprises a plurality of capsules each encapsulating the phase change material, wherein the capsules are arranged in a matrix of thermally conductive and conformable material.
In some variations the thermal regulator is formed of a single body. For example, the thermal regulator comprises a single body comprising the phase change material.
As mentioned, the phase change material is able to include any appropriate phase change material having a phase transition temperature at the appropriate temperature. For example, the phase transition material is an organic phase change material, such as a paraffin. As mentioned, the phase change material is able to comprise a mixture of two or more different phase change materials.
In general, the thermal regulator is configured so that the phase change material is sustained at the phase transition temperature for greater than a minimum time (e.g., 15 minutes, 30 minutes, 45 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 7 hours, 8 hours, or 15 minute increments of any of these). The duration that the phase change material is held at its phase transition temperature depends primarily on the nature of the phase change material, and is related to the rate at which the phase change material releases or absorbs thermal energy as it changes phase. Other factors, including the amount of phase change material, and the ambient (surrounding) temperature and pressure also affect the duration. However, assuming that the phase change material begins with the material completely at an initial phase (e.g., solid or liquid), and assuming that the ambient temperature (e.g., air temperature and the skin temperature of the subject wearing the applicator) are generally the same when comparing different applicators, the material properties of the phase change material as well as the amount of phase change material primarily determine the duration that the phase change material is held at its phase transition temperature. Thus, the thermal regulator is able to be configured so that the phase change material is maintained at about the phase transition temperature for greater than about 30 minutes when the applicator is worn by a subject. In some variations, the thermal regulator is configured so that the phase change material is maintained at about the phase transition temperature for greater than about 6 hours when the applicator is worn by a subject.
In general, the thermal transfer region is configured to transfer thermal energy between the region of the subject's head over the frontal cortex and the thermal regulator region. Thus, the thermal transfer regions is formed of a material having a relatively high thermal conductivity. The thermal transfer region is also able be configured to be flexible and/or form-fitting over the patient's head, to optimize the contact and transfer of thermal energy. For example, the thermal transfer region includes a material having a thermal conductivity of greater than about 0.1 watts per meter kelvin (W/(m*K)) (e.g., greater than about 0.2 W/m*K, 0.3 W/m*K, 0.4 W/m*K, 0.5 W/m*K, 0.5 W/m*K, 0.7 W/m*K, 0.8 W/m*K, 0.9 W/m*K, 1 W/m*K, 2 W/m*K, 5 W/m*K, etc.).
The thermal transfer region is generally configured to position the thermal regulator over just the subject's frontal cortex when the applicator is worn by the subject, or primarily over just the subject's frontal cortex (e.g., over just the frontal cortex and immediately adjacent regions). For example, the thermal transfer region is configured to contact the subject's forehead but not to contact the subject's periorbital or cheek regions of the subject's face when the applicator is worn by the subject. The thermal transfer region is configured to contact the subject's forehead but not to contact the back of the subject's head when the applicator is worn by the subject, and/or the back and sides of the subject's head (generally excluding the temples).
As mentioned, the thermal transfer region includes a layer of thermally conductive material configured to contact the subject's forehead when the applicator is worn by the subject. Examples of thermally conductive materials include fabrics (and/or coated fabrics, etc.) having a relatively high thermal conductivity (e.g., greater than 0.1, 0.2, 0.3, 0.4, 0.5, etc. W/(m*K)). The thermal conductivity is enhanced by including a high thermal conductivity coating (e.g., diamond-like coatings, metal oxides, nitrides, carbides, glass, etc.)
Any of the applicators described herein are able to include an attachment to secure the applicator to the subject's head. For example, an applicator includes a strap configured as a headgear. The headgear is able to contact any portion of the subject's head (e.g., the face, eye orbit, etc.), but typically does not provide thermal contact between the thermal regulatory region and the subject's head. Thus, the exchange of thermal energy between the thermal regulatory region and the subject's head is relatively limited by the thermal transfer region to the region of the subject's head above the frontal cortex. For example, a headgear includes a headband, hat, cap, kerchief, or the like, for holding the thermal transfer region in contact with the appropriate region of the head (e.g., the forehead/scalp), but preventing thermal contact between the thermal regulatory region and the rest of the head/face.
Any of the applicators to enhance a subject's sleep by regulating the temperature of the frontal cortex when worn are able to include: a thermal regulator region comprising a plurality of bodies each enclosing a phase change material having a phase transition between about 10 degrees C. and about 40 degrees C.; a thermal transfer region in thermal communication with the thermal regulator region, wherein the thermal transfer regions is configured to conform to and to contact a subject's head so that the thermal transfer region is positioned against the subject's head over the frontal cortex, further wherein the thermal transfer region is configured to contact and the subject's forehead but not to contact the subject's periorbital or cheek regions of the subject's face to regulate temperature when the applicator is worn by the subject; and a strap configured to hold the thermal transfer region against the subject's head when the subject is sleeping.
Also described herein are methods of enhancing sleep. In general, a method of enhancing sleep includes a method of reducing the sleep onset time, and/or prolonging the duration of sleep (e.g., increasing total sleep time), and/or increasing the quality of sleep, and/or, treating insomnia, and/or treating other neurological disorders by non-invasive temperature regulation of the frontal cortex before or after sleep onset.
For example, described herein are methods of enhancing sleep in a subject, the method comprising: positioning an applicator having a thermal regulator region comprising a plurality of bodies each enclosing a phase change material having a phase transition between about 10 degrees C. and about 40 degrees C. and a thermal transfer region in thermal communication with the thermal regulator region so that the thermal transfer region contacts the subject's forehead but does not contact the periorbital or cheek regions of the subject's face; and maintaining the temperature of the thermal transfer region at the phase transition temperature to enhance the subject's sleep.
The step of positioning comprises positioning the applicator so that the thermal transfer region does not contact the top or back of the subject's head. In any of these variations, the step of positioning comprises adjusting a headgear to hold the applicator to the subject's head.
Maintaining means maintaining the temperature of the thermal regulator region at the phase transition temperature for at least some minimum time (e.g., 30 minutes, 60 min, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 7 hours, 8 hours, etc.). For example, maintaining means maintaining the temperature of the thermal regulator region at the phase temperature for at least 1 hr. In some variations, maintaining comprises maintaining the temperature of the thermal regulator region at the phase temperature for at least 6 hrs.
In general, positioning means adjusting the thermal transfer region of the applicator to conform to the subject's head.
A method of enhancing sleep in a subject includes: positioning an applicator having a thermal regulator region comprising a plurality of bodies each enclosing a phase change material having a phase transition between about 10 degrees C. and about 40 degrees C. and a thermal transfer region in thermal communication with the thermal regulator region so that the thermal transfer region contacts the subject's forehead but does not contact the periorbital, cheek, top or back regions of the subject's head; and maintaining the temperature of the thermal transfer region at the phase transition temperature for more than about 30 minutes to enhance the subject's sleep.
The thermal transfer region is temperature regulated by any appropriate mechanism, particularly passive thermal regulator regions. In some variations, the thermal transfer region is thermally regulated by a phase change material forming the thermal regulator region. There are many types of phase change materials that are able to be utilized. A phase change material (PCM) is a substance with a high heat of fusion which, melting and solidifying at a certain temperature, is capable of storing and releasing relatively large amounts of energy. Heat is absorbed or released when the material changes from solid to liquid and vice versa; thus, PCMs are classified as latent heat storage (LHS) units.
PCMs latent heat storage is achieved through solid-solid, solid-liquid, solid-gas and liquid-gas phase change. However, the phase change used for PCMs is typically the solid-liquid change, as liquid-gas phase changes are not typically practical for use as thermal storage due to the large volumes or high pressures required to store the materials when in their gas phase. Liquid-gas transitions do have a higher heat of transformation than solid-liquid transitions. Solid-solid phase changes are typically very slow and have a rather low heat of transformation.
Solid-liquid PCMs typically behave like sensible heat storage (SHS) materials; their temperature rises as they absorb heat. Unlike conventional SHS, however, when PCMs reach the temperature at which they change phase (their melting temperature) they absorb large amounts of heat at an almost constant temperature. The PCM continues to absorb heat without a significant rise in temperature until all the material is transformed to the liquid phase. When the ambient temperature around a liquid material decreases, the PCM solidifies, releasing its stored latent heat. A large number of PCMs are commercially available in any required temperature range from −5 up to 190° C. Within the human comfort range of 20° to 30° C. (or within 10 degrees C. to 40 degrees C., or within 14 degrees C. to 40 degrees C., etc.), some PCMs are very effective. They store 5 to 14 times more heat per unit volume than conventional storage materials such as water, masonry or rock.
The brain temperature-regulating applicator apparatuses described herein (referred to as non-invasive frontal or pre-frontal cortical stimulation regions) use one or more phase change materials to thermally regulate a region of the subject's head, and therefore a region of the subject's underlying cortex (pre-frontal/frontal cortex) within the therapeutic range to enhance sleep and/or sleep onset. However, such devices should also be configured so that they are able to be comfortably worn. For example, they must conform to the subject's head over the appropriate region, and must be sufficiently light and compact (and in some variation flexible) so that they do not disrupt or prevent sleep, and must prevent tangling and/or disturbing the subject wearing the device while sleeping, including moving while sleeping.
Typically, phase change materials that change from a solid to either a liquid or gas exhibit limited conformability when in the solid state. This lack of conformability impacts the subjects overall comfort. Phase change materials are used in many applications to include relief from pain, swelling and stress reduction, however such materials have not previously been described as part of a device that is capable of enhancing sleep, including reducing sleep onset.
Any of the applicators described herein are able to be configured to applying cooling to enhance sleep, as demonstrated, for example, in U.S. Pat. No. 8,236,038, to the frontal cortex to enhance sleep. Thus, any of the applicators described herein are able to be configured to cool the subject's head over the pre-frontal/frontal cortex to a temperature that is between about 0 degrees C. and about 35 degrees C. (e.g., a temperature between about 10 degrees C. and 30 degrees C., a temperature between about 14 degrees C. and 30 degrees C., etc.) The temperature is selected from within this range and held relatively constant at that temperature for some predetermined amount of time.
Any of the applicators described herein also (or alternatively) are able to be configured to apply generally “warming” (warming relative to the surface temperature of the subject) to the patient's head, e.g., between about 30 degrees C. and about 40 degrees C., e.g., between about 32 degrees C. and about 38 degrees C., etc. Warming has surprisingly been shown recently to enhance sleep in some patients; and particularly warming provide specifically (and/or exclusively) over the pre-frontal/frontal cortical region (e.g., forehead, etc.), and sustained at a relatively constant temperature for a predetermined period of time (e.g., 15 min, 30 min, 1 hour, 2 hours, 3 hours, 4 hours, 5 hours, etc.). As described in greater detail below, for variations in which the applicator includes a phase change material as part of the thermal regulator, the phase change material is chosen so that appropriate warming/cooling temperature is select. Further, before operation of the applicator, the applicator (or at least the thermal regulator portion of the applicator including the phase change material) is able to be cooled or heated beyond the phase transition temperature so that the applicator will passively remove or apply thermal energy once applied to the subject.
In some variations of the apparatuses and systems described herein, the phase change material is formulated to target a specific temperature for the phase change to occur that is beneficial for enhancing sleep, such as sleep quality, onset, duration, and/or for treating insomnia. In one embodiment, the specific temperature is a temperature that is not perceived as uncomfortably cold when cooling temperatures are applied (e.g., typically greater than or about 10° C., e.g., about 14° C.). In warming variations, other specific temperatures are also able to be targeted between about, for example, 36° C. to about 44° C. (e.g., 38° C., 40° C., etc.) The thermal capacity of the phase change material is sufficient to maintain the targeted temperature for a time period ranging from about 15 minutes to over 480 minutes (e.g., over about 15 min., over about 30 min., over about 45 min, over about 1 hr., over about 6 hrs., etc.)
The phase change material is able to be encapsulated in a bio-compatible material suitable for extended contact with the subject's skin, or for contact with a thermal transfer region that directly contacts the skin. In one embodiment, the encapsulating material is flexible and acts as a thermal conductor. Encapsulated phase change material are able to be used in conjunction with a mold to form the material into the shape of the forehead while being cooled below the phase change temperature/heated above the phase change temperature (e.g., if the applicator is intended to apply cooling). The shape of the mold is generic based upon standard anatomy measurements, or is custom shaped to the subjects head above the prefrontal cortex.
In some variations, the phase change material is encapsulated into one compartment within the applicator. For example, a phase change material is present in a large compartment. In some variations, the phase change material is formulated to maintain a high level of flexibility to enhance conformability and comfort.
In some variations, the phase change material is encapsulated into many compartments within the applicator allowing the applicator to become form fitting over the prefrontal cortex. The size of the compartments is able to be the same or vary by location over the pre frontal cortex. In some variations, the compartments are connected or are independent of each other.
In some variations, the phase change material is encapsulated into individual capsules or containers within the applicator, as shown in
In some variations, the phase change material is able to be mixed with other materials to form a matrix of materials such that the phase change material in the solid form is suspended within other materials. Such a matrix produces a more flexible and comfortable applicator.
As mentioned, in some variations, the phase change material is attached to an interface material. The interface material provides a higher degree of formability to the subject's anatomy above the pre frontal cortex than is achieved by the phase change material encapsulations previously discussed. The interface material is typically a thermal transfer region having a relatively high thermal conductivity. For example, a thermal transfer region is a gel material with high thermal conductivity, water or other formable materials that enhance subject comfort, as illustrated in
Examples of phase change material formulations that are able to be used for sleep enhancement include inorganic (e.g., salt hydrates), eutectics (Organic-organic, organic-inorganic, inorganic-inorganic compounds, including paraffins), and Hygroscopic materials.
In use, any of the phase change material devices described herein are able to be prepared by cooling or warming prior to application. For applicators intended to cool the subject's frontal/prefrontal cortex, prior to placing the applicator in position on the subject's forehead over the brain (e.g., frontal, prefrontal) region of interest, the applicator is cooled to, or in some variations, below, the phase change temperature by any appropriate method. In some variations the applicator is cooled by placing in a refrigerator until the phase change occurs. In other variations, a bedside cooling device is used to achieve the required temperature for phase change to occur. This bedside cooling device is able to cool the applicator utilizing any readily available refrigeration techniques including, but not limited to: compressor driven and/or Pelletier refrigeration. In any of the system/device variations described, a cooling mold is able to be used to pre-shape the applicator to conform to the subject's forehead. This provides for additional comfort and enhances the thermal contact of the applicator. Once positioned on the subject's forehead the applicator maintains the temperature in a narrow temperature range due to the heat absorbing characteristics of the phase change material. Similarly, in variations in which the applicator is intended to warm the subject by passively holding the thermal regulator at a warming temperature (above ambient skin temperature), the applicator or just the thermal regulator region is heated above the transition temperature of the phase change material in the applicator. For example, a phase change material is a Sodium Acetate solution that produces heat when it crystalizes. The crystallization of Sodium Acetate occurs when heterogeneous nucleation is initiated (e.g., a nucleation agent that is below the phase transition temperature).
Two variations of side views are shown in
In some variations, the apparatuses and systems utilize evaporative cooling to maintain the temperature of the applicator at the desired therapeutic temperature to enhance sleep. There are many forms of evaporative cooling commercially available, however, to date no effective evaporative cooling systems or devices have been formulated or configured specifically for sleep enhancement or the treatment of insomnia. As described herein, any appropriate evaporative cooling systems, devices, or materials are able to be engineered to meet the specific requirements for sleep enhancement and the treatment of insomnia.
For example, in some variations, the evaporative cooling device includes sodium polyacrylate crystals to enhance moisture retention. In some variations the evaporative cooling applicator is manufactured from hydrophilic fibers specifically formulated and produced in a manner to enhance moisture retention. In such a variation, the applicator is produced from the hydrophilic textile material and is shaped to conform to cover the subject's forehead or possibly the entire frontal cortex area by common textile manufacturing techniques. The hydrophilic textile material is held in place by a headgear or adjustable strap. In use, the hydrophilic material is saturated in water prior to being placed in position on the subject and cooling of the pre frontal cortex area occurs from the evaporation of the moisture contained within the applicator.
In one embodiment, an evaporative cooling device is configured so that the applicator does not leak or spill water. For example, the evaporative cooling device is sealed around all but one or more evaporative air ports; the air ports are configured to provided fluid locks that minimize or prevent fluid leakage.
As discussed above, any of the applicators described herein are able to be used with a headgear that is specifically configured to maintain the applicator in thermal contact with the subject's head in a snug but non-restrictive manner. Thus, in some variations the applicator is held in position with a headgear. The headgear maintains thermal contact of the applicator to provide regional cooling of the area in proximity to the frontal cortex. In one embodiment, the headgear is configured to allow the subject to adjust the amount of contact pressure applied to the applicator and to adjust for comfort, while maintaining the position of the thermal transfer region of the applicator over the frontal cortex. The headgear is configured from a variety of materials. In some variations, where the cooling is achieved by a phase change material, the headgear includes an insulation material that covers the surface of the applicator distal to the subject to reduce parasitic heat from accelerating the phase change. In one embodiment, the insulation material is an elastic material or covered with an elastic material that induces increased contact pressure of the applicator to the subject's forehead when stretched by adjustable straps wrapping the circumference of the subjects head. The adjustable straps are produced from any suitable material either exhibiting an elastic characteristic or not and incorporate any adjustable feature readily available such as Velcro, snaps, buttons, hooks etc. In some variations, the adjustment features allow for macro adjustment of the circumferential head size and secondary adjustment features to micro adjust specific areas of the applicator to ensure optimal thermal contact and comfort. In some variations, the headgear is produced from an elastic material in fixed sizes without adjustability i.e., small, medium and large.
In one embodiment, the headgear utilized for an evaporative cooling applicator is configured so that it does not cover the distal side of the evaporative cooling material with an insulation layer, as this inhibits the evaporative process.
In one embodiment, the headgear is reusable and/or separate from the applicator. Alternatively, the headgear is integral with the applicator. In one embodiment, the headgear is constructed of a singular piece to allow thermal contact for the regional cooling. For example, the headgear includes a thermal transfer region oriented so that it is positioned against the head over the subject's frontal (and/or prefrontal) cortex region. The other regions of the headgear are able to be thermally insulated. In one embodiment, the headgear includes a pocket or clips to secure an applicator against the subject's head. In some variations, the applicator is one or more standard sizes, and the headgear is provided in different sizes that fit the standard size(s) of the applicator. The headgear is typically adjustable. In one embodiment, the headgear is cushioned, particularly in the regions surrounding the applicator.
In some variations, the headgear is constructed of multiple pieces for better thermal contact and comfort of the patient.
As mentioned, in some variations, the headgear is constructed to allow adjustment to allow for better thermal contact and comfort of the patient.
As mentioned, a headgear is able to be used for single use, or is able to be reusable. For example, in some variations, the headgear is a singular use and replaced on each application.
When a feature or element is herein referred to as being “on” another feature or element, it is directly on the other feature or element or intervening features and/or elements are also present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that, when a feature or element is referred to as being “connected”, “attached” or “coupled” to another feature or element, it is directly connected, attached or coupled to the other feature or element or intervening features or elements are present. In contrast, when a feature or element is referred to as being “directly connected”, “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown are able to apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature is able to have portions that overlap or underlie the adjacent feature.
Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and are abbreviated as “/”.
Spatially relative terms, such as “under”, “below”, “lower”, “over”, “upper” and the like, are used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features are then oriented “over” the other elements or features. Thus, the exemplary term “under” encompasses both an orientation of over and under. The device is able to be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly”, “downwardly”, “vertical”, “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.
Although the terms “first” and “second” are used herein to describe various features/elements, these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms are used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below is able to be termed a second feature/element, and similarly, a second feature/element discussed below is able to be termed a first feature/element without departing from the teachings of the present invention.
As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers are read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” is used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value has a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), +/−10% of the stated value (or range of values), etc. Any numerical range recited herein is intended to include all sub-ranges subsumed therein.
Although various illustrative embodiments are described above, any of a number of changes is able to be made to various embodiments without departing from the scope of the invention as described by the claims. For example, the order in which various described method steps are performed is often changed in alternative embodiments, and in other alternative embodiments one or more method steps are skipped altogether. Optional features of various device and system embodiments are included in some embodiments and not in others. Therefore, the foregoing description is provided primarily for exemplary purposes and should not be interpreted to limit the scope of the invention as it is set forth in the claims.
The examples and illustrations included herein show, by way of illustration and not of limitation, specific embodiments in which the subject matter is practiced. As mentioned, other embodiments are utilized and derived there from, such that structural and logical substitutions and changes are able to be made without departing from the scope of this disclosure. Such embodiments of the inventive subject matter are referred to herein individually or collectively by the term “invention” merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept, if more than one is, in fact, disclosed. Thus, although specific embodiments have been illustrated and described herein, any arrangement calculated to achieve the same purpose is able to be substituted for the specific embodiments shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments. Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reviewing the above description.
This application is related to and claims priority from the following US patents and patent applications: this application is a continuation of U.S. patent application Ser. No. 15/921,528, filed Mar. 14, 2018, which is a continuation-in-part of U.S. patent application Ser. No. 14/435,515, filed Apr. 14, 2015, which is a 371 of International Patent Application No. PCT/US2013/070251, filed Nov. 15, 2013, which claims priority to U.S. Provisional Patent Application No. 61/727,054, filed Nov. 15, 2012, and U.S. Provisional Patent Application No. 61/859,161, filed Jul. 26, 2013, each of which is incorporated herein by reference in their entirety. U.S. patent application Ser. No. 15/921,528 is also a continuation-in-part of U.S. patent application Ser. No. 15/597,057, filed on May 16, 2017, which is a continuation-in-part of U.S. patent application Ser. No. 14/749,590, filed on Jun. 24, 2015 and issued as U.S. Pat. No. 9,669,185, which is a continuation of U.S. patent application Ser. No. 13/868,015, filed Apr. 22, 2013 and issued as U.S. Pat. No. 9,089,400, which is a continuation of U.S. patent application Ser. No. 13/019,477, filed Feb. 2, 2011 and issued as U.S. Pat. No. 8,425,583, which claims priority to U.S. Provisional Patent Application No. 61/300,768, filed Feb. 2, 2010, each of which is incorporated herein by reference in their entirety. U.S. patent application Ser. No. 13/019,477 is also a continuation-in-part of U.S. patent application Ser. No. 11/788,694, filed Apr. 20, 2007 and issued as U.S. Pat. No. 8,236,038, which claims priority to U.S. Provisional Patent Application No. 60/793,680, filed on Apr. 20, 2006, each of which is incorporated herein by reference in their entirety. U.S. patent application Ser. No. 13/019,477 is also a continuation-in-part of U.S. patent application Ser. No. 12/288,417, filed Oct. 20, 2008 and issued as U.S. Pat. No. 9,492,313, which is a continuation-in-part of U.S. patent application Ser. No. 11/788,694, filed Apr. 20, 2007 and issued as U.S. Pat. No. 8,236,038, which claims priority to U.S. Provisional Patent Application No. 60/793,680, filed on Apr. 20, 2006, which is incorporated herein by reference in its entirety.
| Number | Date | Country | |
|---|---|---|---|
| 61727054 | Nov 2012 | US | |
| 61859161 | Jul 2013 | US | |
| 61300768 | Feb 2010 | US | |
| 60793680 | Apr 2006 | US | |
| 60793680 | Apr 2006 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15921528 | Mar 2018 | US |
| Child | 17727341 | US | |
| Parent | 13868015 | Apr 2013 | US |
| Child | 14749590 | US | |
| Parent | 13019477 | Feb 2011 | US |
| Child | 13868015 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 14435515 | Apr 2015 | US |
| Child | 15921528 | US | |
| Parent | 15597057 | May 2017 | US |
| Child | 15921528 | US | |
| Parent | 14749590 | Jun 2015 | US |
| Child | 15597057 | US | |
| Parent | 11788694 | Apr 2007 | US |
| Child | 13019477 | US | |
| Parent | 12288417 | Oct 2008 | US |
| Child | 13019477 | US | |
| Parent | 11788694 | Apr 2007 | US |
| Child | 12288417 | US |
